α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages
- PMID: 36162872
- PMCID: PMC10829398
- DOI: 10.4049/jimmunol.2200227
α1-Antitrypsin Binds to the Glucocorticoid Receptor with Anti-Inflammatory and Antimycobacterial Significance in Macrophages
Abstract
α1-Antitrypsin (AAT), a serine protease inhibitor, is the third most abundant protein in plasma. Although the best-known function of AAT is irreversible inhibition of elastase, AAT is an acute-phase reactant and is increasingly recognized to have a panoply of other functions, including as an anti-inflammatory mediator and a host-protective molecule against various pathogens. Although a canonical receptor for AAT has not been identified, AAT can be internalized into the cytoplasm and is known to affect gene regulation. Because AAT has anti-inflammatory properties, we examined whether AAT binds the cytoplasmic glucocorticoid receptor (GR) in human macrophages. We report the finding that AAT binds to GR using several approaches, including coimmunoprecipitation, mass spectrometry, and microscale thermophoresis. We also performed in silico molecular modeling and found that binding between AAT and GR has a plausible stereochemical basis. The significance of this interaction in macrophages is evinced by AAT inhibition of LPS-induced NF-κB activation and IL-8 production as well as AAT induction of angiopoietin-like 4 protein, which are, in part, dependent on GR. Furthermore, this AAT-GR interaction contributes to a host-protective role against mycobacteria in macrophages. In summary, this study identifies a new mechanism for the gene regulation, anti-inflammatory, and host-defense properties of AAT.
Copyright © 2022 by The American Association of Immunologists, Inc.
Conflict of interest statement
Conflict of interest
ANG holds equity in Psammiad Therapeutics. All other authors declare that they have no conflicts of interest with the contents of this article.
Figures
References
-
- de Serres F, and Blanco I. 2014. Role of alpha-1 antitrypsin in human health and disease. J Intern Med 276: 311–335. - PubMed
-
- Parr DG, Guest PG, Reynolds JH, Dowson LJ, and Stockley RA. 2007. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 176: 1215–1221. - PubMed
-
- Strnad P, McElvaney NG, and Lomas DA. 2020. Alpha(1)-Antitrypsin Deficiency. N Engl J Med 382: 1443–1455. - PubMed
-
- Bryan CL, Beard KS, Pott GB, Rahkola J, Gardner EM, Janoff EN, and Shapiro L. 2010. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations. Clin Invest Med 33: E384–E389. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
